{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:27:49Z","timestamp":1761676069632},"reference-count":35,"publisher":"Wiley","issue":"3-4","license":[{"start":{"date-parts":[[2013,5,9]],"date-time":"2013-05-09T00:00:00Z","timestamp":1368057600000},"content-version":"vor","delay-in-days":7514,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J Rep Immunol"],"published-print":{"date-parts":[[1992,10,12]]},"abstract":"<jats:p><jats:bold>ABSTRACT: <\/jats:bold> Epidemiological and immunological evidence has suggested that female sex hormones may play a role in the etiology and course of autoimmune diseases such as rheumatoid arthritis (RA). In this review the present clinical data with regard to estrogens and RA are discussed, with emphasis on the possible preventive effect of oral contraceptives on the incidence of RA and on the possibility of using estrogens as adjuvant therapy in RA. It is concluded that oral contraceptives may mitigate or postpone the onset of RA slightly, but that estrogens are not able to alleviate the symptoms of RA. Presently there is no evidence to promote the use of estrogens in preventing or treating RA in females.<\/jats:p>","DOI":"10.1111\/j.1600-0897.1992.tb00800.x","type":"journal-article","created":{"date-parts":[[2013,5,9]],"date-time":"2013-05-09T11:38:20Z","timestamp":1368099500000},"page":"231-234","source":"Crossref","is-referenced-by-count":45,"title":["Estrogens and Rheumatoid Arthritis"],"prefix":"10.1111","volume":"28","author":[{"given":"J.W.J.","family":"BIJLSMA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.R.","family":"VAN DEN BRINK","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,5,9]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"1620","article-title":"Onset of symptoms of rheumatoid arthritis in relation to age, sex and menopausal transition","volume":"17","author":"Goemaere S","year":"1990","journal-title":"J Rheumatol"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0950-3579(05)80344-9"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780280202"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.48.1.1"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1210\/edrv-5-3-435"},{"key":"e_1_2_1_7_2","unstructured":"LahitaRG.The effects of sex steroids on the rheumatic diseases. [Report of this conference]."},{"key":"e_1_2_1_8_2","article-title":"Influence of steroid hormones on proliferation of peripheral blood mononuclear cells in patients with rheumatoid arthritis","author":"Brink HR","year":"1992","journal-title":"Br J Rheumatol."},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.3109\/03009748309102886"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.50.2.71"},{"key":"e_1_2_1_11_2","unstructured":"SpectorTD.Rheumatoid arthritis an pregnancy: An overview. [Report of this conference]."},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(83)90789-1"},{"key":"e_1_2_1_13_2","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.4049\/jimmunol.122.5.1978","article-title":"Mechanism of immunosuppression of progesterone on matenal lymphocyte activation during pregnancy","volume":"122","author":"Clemens LE","year":"1979","journal-title":"J Immunol"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1210520"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780310805"},{"key":"e_1_2_1_16_2","first-page":"1019","article-title":"Sex hormone status in women suffering from rheumatoid arthritis","volume":"13","author":"Cutolo MN","year":"1986","journal-title":"J Rheumatol"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/26.4.316"},{"key":"e_1_2_1_18_2","first-page":"445","article-title":"Transient hypogonadotrophic hypogonadism caused by critical illness","volume":"60","author":"Woolfe PD","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_2_1_19_2","unstructured":"BrinkHRvan den BlankensteinMA KoppeschaarHPF BijlsmaJWJ.Influence of disease activity on steroid hormone levels in peripheral blood of patients with rheumatoid arthritis. Submitted."},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1210520"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/27.6.440"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780340102"},{"key":"e_1_2_1_23_2","first-page":"569","article-title":"Royal College of General Practioners study. Reduction in incidence of rheumatoid arthritis associated with oral contraceptives","author":"Wingrave SJ","year":"1978","journal-title":"Lancet"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a112878"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/XXVIII.suppl_1.13"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780331002"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.49.10.744"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780341205"},{"key":"e_1_2_1_29_2","first-page":"284","article-title":"The use of norethynodrel (Enovid) in the treatment of rheumatoid arthritis","volume":"5","author":"Blais JA","year":"1962","journal-title":"Arthritis Rheum"},{"key":"e_1_2_1_30_2","first-page":"350","article-title":"Arthrite rheumatoide traite\u00e9 par norethynodrel associe\u00e9 mestranol: Aspects cliniques et tests de laboratoire","volume":"95","author":"Demers R","year":"1966","journal-title":"Can Med Assoc J"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1964.03070160059013"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780060111"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.46.10.777"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/XXVIII.suppl_1.28"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/XXVIII.suppl_1.24"},{"key":"e_1_2_1_36_2","unstructured":"BrinkHR EverdingenAA WijkMJG JacobsJWG BijlsmaJWJ.Adjuvant estrogen therapy does not influence disease activity in postmenopausal female patients with rheumatoid arthritis. Submitted."}],"container-title":["American Journal of Reproductive Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0897.1992.tb00800.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0897.1992.tb00800.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T09:32:03Z","timestamp":1693387923000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0897.1992.tb00800.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,10,12]]},"references-count":35,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[1992,10,12]]}},"alternative-id":["10.1111\/j.1600-0897.1992.tb00800.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0897.1992.tb00800.x","archive":["Portico"],"relation":{},"ISSN":["1046-7408","1600-0897"],"issn-type":[{"value":"1046-7408","type":"print"},{"value":"1600-0897","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,10,12]]}}}